Fibrin Glue Market Key Highlights:
- Market Size (2024): USD 45,190 Million
- Projected Market Size (2034): USD 74,310 Million
- CAGR (2024-2034): 5.1%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Fibrin Glue Market Definition
The fibrin glue market is a crucial segment of the healthcare industry. This industry deals with the development and distribution of adhesives based on biological tissue used for several surgical procedures. There are several products developed by this industry, including hemostats, adhesives, sealants, and others. It is generally available in various forms on the market, including liquid form, powdered form, patch form, and others. The rapid advancements in surgical technologies have increased the demand for fibrin glue, thereby driving market expansion. This market is expected to rise significantly with the growth of the pharmaceutical industry across the world.
The rising adoption of minimally invasive surgical procedures by modern surgeons has increased the use of fibrin glue, which in turn boosts the market growth. Also, a rise in the number of effective health insurance policies coupled with rapid developments in the pharmaceutical sector is playing a massive role in positioning the industry in a positive trajectory. Moreover, the growing application of these substances in several surgical procedures, orthopedic surgery, cardiovascular surgery, general surgery, transplant surgery, and some others, is anticipated to propel the growth of the fibrin glue market. The growing use of fibrin glue in drug delivery systems, along with the rapid adoption of modified fibrin in surgeries, is expected to create opportunities for market players in the upcoming years.
Fibrin Glue Market Segmentation:
By Product
- Viral Inactivation
- Autologous Donation
- Recombinant Production
- Others
By Type
- Hemostat
- Adhesive
- Sealant
By Application
- Cardiac surgery
- Pulmonary surgery
- Burn bleeding
- Vascular surgeries
- Orthopedic surgeries
- Lacerations of liver and spleen
- Neurosurgery
- Plastic surgery
- General surgery
- Wound management
Fibrin Glue Market Companies:
- Vivostat A/S
- Kaketsuken
- Johnson & Johnson
- Baxter International Inc.
- CSL Behring
- STB Lifesaving Technologies
- Zimmer Biomet Holdings, Inc.
- Takeda Pharmaceutical Company Limited
- Mallinckrodt Plc
- Shanghai RAAS Blood Products Co. Ltd.
- Hualan Biological Engineering Inc.
- Bayer
- Shanghai RAAS
- Cryolife
- Haemcure Corporation
- Omrix Biopharmaceutical, Inc.
- Interpore Cross
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
